HALOZYME THERAPEUTICS, INC. — Earnings
Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR
Next earnings (estimated): Wed, April 1, 2026 — 30 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)
Recent earnings · last 8 quarters
| Quarter end | Revenue | YoY | Net Income | YoY | Op. Margin |
|---|---|---|---|---|---|
| 2025-12-31 | $452M | ↑+51.6% | — | — | — |
| 2025-09-30 | $354M | ↑+22.1% | $175M | ↑+27.9% | 61.5% |
| 2025-06-30 | $326M | ↑+40.8% | $165M | ↑+77.1% | 62.2% |
| 2025-03-31 | $265M | ↑+35.2% | $118M | ↑+53.7% | 53.4% |
| 2024-12-31 | $298M | ↑+29.5% | $137M | ↑+60.5% | 58.9% |
| 2024-09-30 | $290M | ↑+34.3% | $137M | ↑+67.4% | 56.3% |
| 2024-06-30 | $231M | ↑+4.7% | $93M | ↑+24.7% | 50.7% |
| 2024-03-31 | $196M | ↑+20.8% | $77M | ↑+93.9% | 48.8% |
Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.
Last earnings · FY2025 (Q4)
Revenue
$452M
↑+51.6% +$154M YoY
Net Income
$245M
↑+78.5% +$108M YoY
Earnings surprise · last 8 quarters
YoY % change · proxy for analyst surprise until estimates landEPS history · last 10 fiscal years
diluted, GAAP, annualNote: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.
Margin trends · 63 quarters
margin trajectory tells the operating-leverage storyGross Margin↓-6.1pts
5.1%
Operating Margin↑+5.3pts
61.5%
Net Margin↑+2.2pts
49.5%
Go deeper
HALO Sankey — flow of dollars
See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.
Open SankeyHALO Key Metrics — EPS, ROE, ROIC
10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.
Open Key Metrics